Pharmacodynamics of cefazolin in the presence of normal and impaired renal function
- PMID: 4758839
- PMCID: PMC444558
- DOI: 10.1128/AAC.4.3.366
Pharmacodynamics of cefazolin in the presence of normal and impaired renal function
Abstract
The excretion of cefazolin, a new cephalosporin antibiotic, was studied in subjects with normal and impaired renal function. Twelve subjects with creatinine clearances ranging from 0 to 144 ml per min per 1.73 m(2) were given a single 500-mg intramuscular dose of cefazolin. Serum and urine levels were determined at intervals by agar diffusion. Peak serum levels in normals ranged from 44 to 70 mug/ml and occurred 30 to 60 min after injection. The mean serum half-life in normals was 1.6 h, and this was prolonged from 20 to 40% by simultaneous administration of probenecid. The total elimination constant varied linearly with the creatinine clearance in patients with renal impairment. The serum half-life in anephric patients was about 42 h. The fractional clearance of the drug varied directly with the serum level. Peak urine levels ranged from 60 to over 2,000 mug/ml, and more than 90% of the dose was recovered in the urine of normals during the first 24 h. The data suggest that cefazolin is cleared primarily by the glomerulus, with tubular and biliary secretion playing a secondary role.
Similar articles
-
Pharmacokinetics of cefazolin in normal and uremic subjects.Clin Pharmacol Ther. 1974 Apr;15(4):344-53. doi: 10.1002/cpt1974154344. Clin Pharmacol Ther. 1974. PMID: 4821438 No abstract available.
-
Cefazolin plasma concentrations and urinary excretion in patients with renal impairment.J Clin Pharmacol. 1974 Oct;14(10):560-6. doi: 10.1002/j.1552-4604.1974.tb01371.x. J Clin Pharmacol. 1974. PMID: 4430733 No abstract available.
-
Pharmacokinetics of cefazolin, a new cephalosporin antibiotic, in normal and uraemic patients.Curr Ther Res Clin Exp. 1974 Sep;16(9):878-89. Curr Ther Res Clin Exp. 1974. PMID: 4214662 No abstract available.
-
Pharmacokinetics of cefoperazone: a review.Drugs. 1981;22 Suppl 1:35-45. doi: 10.2165/00003495-198100221-00010. Drugs. 1981. PMID: 6456890 Review.
-
A review and summary of the pharmacokinetics of cefoperazone: a new, extended-spectrum beta-lactam antibiotic.Ther Drug Monit. 1981;3(2):121-8. doi: 10.1097/00007691-198102000-00002. Ther Drug Monit. 1981. PMID: 6455787 Review.
Cited by
-
Cephalosporin-probenecid drug interactions.Clin Pharmacokinet. 1993 Apr;24(4):289-300. doi: 10.2165/00003088-199324040-00003. Clin Pharmacokinet. 1993. PMID: 8491057 Review.
-
Clinical pharmacokinetics of probenecid.Clin Pharmacokinet. 1981 Mar-Apr;6(2):135-51. doi: 10.2165/00003088-198106020-00004. Clin Pharmacokinet. 1981. PMID: 7011657 Review.
-
A comparison of empiric therapy with cefazolin versus ceftriaxone for patients with complicated urinary tract infections in a tertiary care veterans affairs medical center.BMC Infect Dis. 2025 Mar 3;25(1):302. doi: 10.1186/s12879-025-10494-5. BMC Infect Dis. 2025. PMID: 40033251 Free PMC article.
-
Additional doses of prophylactic antibiotics post-arthroplasty: Are there any benefits?J Perioper Pract. 2025 Jul-Aug;35(7-8):315-321. doi: 10.1177/17504589241252019. Epub 2024 Jun 14. J Perioper Pract. 2025. PMID: 38877723 Free PMC article. Review.
-
Determination of appropriate weight-based cutoffs for empiric cefazolin dosing using data from a phase 1 pharmacokinetics and safety study of cefazolin administered for surgical prophylaxis in pediatric patients aged 10 to 12 years.Antimicrob Agents Chemother. 2015 Jul;59(7):4173-80. doi: 10.1128/AAC.00082-15. Epub 2015 May 4. Antimicrob Agents Chemother. 2015. PMID: 25941220 Free PMC article. Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources